Inventor · disambiguated record
S. Derek Turner
Also filed as: TURNER S D · TURNER S DEREK
39 granted patents·1 pending application·568 citations·filing 2001–2017
98Inventor score
Top patents by PatentIndex Score
40 records- 0198US7655621B2Cross-linked glycopeptide-cephalosporin antibioticsTHERAVANCE INC·Filed 2007·Granted Feb 2, 2010·26 cites·12 claims
- 0298US7649080B2Cross-linked glycopeptide-cephalosporin antibioticsTHERAVANCE INC·Filed 2007·Granted Jan 19, 2010·24 cites·18 claims
- 0398US7601690B2Cross-linked glycopeptide-cephalosporin antibioticsTHERAVANCE INC·Filed 2007·Granted Oct 13, 2009·25 cites·6 claims
- 0498US7553962B2Cross-linked glycopeptide-cephalosporin antibioticsTHERAVANCE INC·Filed 2007·Granted Jun 30, 2009·21 cites·24 claims
- 0597US7375114B2Quinolinone-carboxamide compounds as 5-HT4 receptor agonistsTHERAVANCE INC·Filed 2005·Granted May 20, 2008·41 cites·17 claims
- 0697US7341993B2Cross-linked glycopeptide—cephalosporin antibioticsTHERAVANCE INC·Filed 2005·Granted Mar 11, 2008·22 cites·2 claims
- 0797US6974797B2Cross-linked glycopeptide-cephalosporin antibioticsTHERAVANCE INC·Filed 2002·Granted Dec 13, 2005·45 cites·25 claims
- 0896US7728127B2Cross-linked glycopeptide-cephalosporin antibioticsTHERAVANCE INC·Filed 2007·Granted Jun 1, 2010·20 cites·17 claims
- 0995US6878686B2Cross-linked glycopeptide-cephalosporin antibioticsTHERAVANCE INC·Filed 2003·Granted Apr 12, 2005·49 cites·27 claims
- 1094US7713931B2Cross-linked glycopeptide-cephalosporin antibioticsTHERAVANCE INC·Filed 2007·Granted May 11, 2010·7 cites·19 claims
- 1194US7351704B2Indazole-carboxamide compounds as 5-HT4 receptor agonistsTHERAVANCE INC·Filed 2005·Granted Apr 1, 2008·25 cites·19 claims
- 1294US6756400B2Sodium channel modulatorsTHERAVANCE INC·Filed 2001·Granted Jun 29, 2004·36 cites·14 claims
- 1393US7728006B2Quinolinone-carboxamide compounds as 5-HT4 receptor agonistsTHERAVANCE INC·Filed 2005·Granted Jun 1, 2010·11 cites·18 claims
- 1493US7592355B2Quinolinone-carboxamide compounds as 5-HT, receptor agonistsTHERAVANCE INC·Filed 2007·Granted Sep 22, 2009·13 cites·20 claims
- 1593US7419989B2Indazole-carboxamide compoundsTHERAVANCE INC·Filed 2005·Granted Sep 2, 2008·19 cites·12 claims
- 1693US7399862B25-HT4 receptor agonist compoundsTHERAVANCE INC·Filed 2005·Granted Jul 15, 2008·26 cites·12 claims
- 1793US6995138B2Cross-linked glycopeptide-cephalosporin antibioticsTHERAVANCE INC·Filed 2004·Granted Feb 7, 2006·34 cites·6 claims
- 1892US7763637B2Quinolinone-carboxamide compounds as 5-HT4, receptor agonistsTHERAVANCE INC·Filed 2008·Granted Jul 27, 2010·12 cites·19 claims
- 1992US7317022B2Benzoimidazolone-carboxamide compounds as 5-HT4 receptors agonistsTHERAVANCE INC·Filed 2006·Granted Jan 8, 2008·19 cites·15 claims
- 2090US7534889B25-HT4 receptor agonist compoundsTHERAVANCE INC·Filed 2008·Granted May 19, 2009·13 cites·16 claims
- 2190US7183323B2Sodium channel modulatorsTHERAVANCE INC·Filed 2004·Granted Feb 27, 2007·20 cites·5 claims
- 2288US8575192B2Quinolinone-carboxamide compounds as 5-HT4 receptor agonistsMARQUESS DANIEL·Filed 2012·Granted Nov 5, 2013·6 cites·18 claims
- 2388US7446114B2Quinolinone compounds as 5-HT4 receptor agonistsTHERAVANCE INC·Filed 2006·Granted Nov 4, 2008·10 cites·15 claims
- 2487US8962653B2Quinolinone-carboxamide compounds as 5-HT4 receptor agonistsMARQUESS DANIEL·Filed 2013·Granted Feb 24, 2015·5 cites·11 claims
- 2586US8163920B2Quinolinone-carboxamide compounds as 5-HT4 receptor agonistsMARQUESS DANIEL·Filed 2010·Granted Apr 24, 2012·5 cites·4 claims
- 2686US7728004B2Crystalline form of a quinolinone-carboxamide compoundTHERAVANCE INC·Filed 2006·Granted Jun 1, 2010·6 cites·7 claims
- 2785US7875629B2Quinolinone compounds as 5-HT4 receptor agonistsTHERAVANCE INC·Filed 2008·Granted Jan 25, 2011·6 cites·11 claims
- 2884US8658671B2Crystalline form of a quinolinone-carboxamide compoundFATHEREE PAUL R·Filed 2010·Granted Feb 25, 2014·5 cites·6 claims
- 2984US8309575B2Quinolinone-carboxamide compounds as 5-HT4 receptor agonistsMARQUESS DANIEL·Filed 2010·Granted Nov 13, 2012·5 cites·5 claims
- 3083US9353106B2Quinolinone-carboxamide compounds as 5-HT4 receptor agonistsMARQUESS DANIEL·Filed 2015·Granted May 31, 2016·2 cites·9 claims
- 3182US7772239B2Benzoimidazolone-carboxamide compounds as 5-HT4 receptor agonistsTHERAVANCE INC·Filed 2007·Granted Aug 10, 2010·4 cites·16 claims
- 3281US9873692B2Quinolinone-carboxamide compounds as 5-HT4 receptor agonistsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2017·Granted Jan 23, 2018·1 cites·2 claims
- 3379US9630960B2Quinolinone-carboxamide compounds as 5-HT4 receptor agonistsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2016·Granted Apr 25, 2017·1 cites·2 claims
- 3478US8084417B2Cross-linked glycopeptide-cephalosporin antibioticsMARQUESS DANIEL·Filed 2008·Granted Dec 27, 2011·1 cites·6 claims
- 3573US9402840B2Crystalline form of a quinolinone-carboxamide compoundFATHEREE PAUL R·Filed 2015·Granted Aug 2, 2016·1 cites·12 claims
- 3673US9126994B2Crystalline form of a quinolinone-carboxamide compoundFATHEREE PAUL R·Filed 2014·Granted Sep 8, 2015·1 cites·15 claims
- 3771US8044045B2Indazole-carboxamide compounds as 5-HT4 receptor agonistsTHERAVANCE INC·Filed 2010·Granted Oct 25, 2011·1 cites·10 claims
- 3862US7786136B2Indazole-carboxamide compoundsTHERAVANCE INC·Filed 2008·Granted Aug 31, 2010·0 cites·11 claims
- 3952US8003664B2Indazole-carboxamide compoundsTHERAVANCE INC·Filed 2010·Granted Aug 23, 2011·0 cites·12 claims
- 4044US2006183901A1Crystalline form of an indazole-carboxamide compoundTHERAVANCE INC·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when S. Derek Turner files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →